检索结果 - Gail Walkinshaw

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.

    Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease. 由 Gail Walkinshaw, Catherine Waters

    出版 1995
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Inhibition of HIF prolyl-4-hydroxylases by FG-4497 Reduces Brain Tissue Injury and Edema Formation during Ischemic Stroke

    Inhibition of HIF prolyl-4-hydroxylases by FG-4497 Reduces Brain Tissue Injury and Edema Formation during Ischemic Stroke 由 Stefan Reischl, Lexiao Li, Gail Walkinshaw, Lee A. Flippin, Hugo H. Marti, Reiner Kunze

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Pharmacologic stabilization of HIF-1α increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation

    Pharmacologic stabilization of HIF-1α increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation 由 Catherine E. Forristal, Ingrid G. Winkler, Bianca Nowlan, Valérie Barbier, Gail Walkinshaw, Jean-Pierre Lévesque

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α

    HIF-1α is required for hematopoietic stem cell mobilization and 4-prolyl hydroxylase inhibitors enhance mobilization by stabilizing HIF-1α 由 Catherine E. Forristal, Bianca Nowlan, Rebecca Jacobsen, Valérie Barbier, Gail Walkinshaw, Carl R. Walkley, Ingrid G. Winkler, Jean-Pierre Lévesque

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis

    Transmembrane prolyl 4-hydroxylase is a fourth prolyl 4-hydroxylase regulating EPO production and erythropoiesis 由 Anu Laitala, Ellinoora Aro, Gail Walkinshaw, Joni M. Mäki, Maarit Rossi, Minna Heikkilä, Eeva‐Riitta Savolainen, Michael Arend, Kari I. Kivirikko, Peppi Koivunen, Johanna Myllyharju

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis

    Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis 由 Lea Rahtu‐Korpela, Jenni Määttä, Elitsa Y. Dimova, Sohvi Hörkkö, Helena Gylling, Gail Walkinshaw, Jukka Hakkola, Kari I. Kivirikko, Johanna Myllyharju, Raisa Serpi, Peppi Koivunen

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction

    HIF Prolyl 4-Hydroxylase-2 Inhibition Improves Glucose and Lipid Metabolism and Protects Against Obesity and Metabolic Dysfunction 由 Lea Rahtu‐Korpela, Sara Karsikas, Sohvi Hörkkö, Roberto Blanco Sequeiros, Eveliina Lammentausta, Kari A. Mäkelä, Karl‐Heinz Herzig, Gail Walkinshaw, Kari I. Kivirikko, Johanna Myllyharju, Raisa Serpi, Peppi Koivunen

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

    Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations 由 Derek J. Hausenloy, Gary F. Baxter, Robert M. Bell, Hans Erik Bøtker, Sean M. Davidson, James M. Downey, Gerd Heusch, Masafumi Kitakaze, Sandrine Lecour, Robert M. Mentzer, Mihaela Mocanu, Michel Ovize, Rainer Schulz, Richard P. Shannon, John M. Walker, Gail Walkinshaw, Derek M. Yellon

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease

    Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease 由 Ughetta del Balzo, Pierre Signore, Gail Walkinshaw, Todd Seeley, Mitchell C. Brenner, Qingjian Wang, Guangjie Guo, Michael Arend, Lee A. Flippin, F. Aisha Chow, David C. Gervasi, Christian H. Kjaergaard, Ingrid Langsetmo, Volkmar Guenzler, David Y. Liu, S J Klaus, Al Lin, Thomas B. Neff

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: